Cooper Companies Inc  

(Public, NYSE:COO)   Watch this stock  
Find more results for Daniel R. Cooper
+0.95 (0.53%)
May 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 178.88 - 182.20
52 week 127.36 - 190.00
Open 179.72
Vol / Avg. 233,906.00/287,705.00
Mkt cap 8.68B
P/E 34.17
Div/yield 0.03/0.03
EPS 5.29
Shares 48.29M
Beta 0.09
Inst. own 101%
Jun 4, 2015
Q2 2015 Cooper Companies Inc Earnings Call - 5:00PM EDT - Add to calendar
Jun 4, 2015
Q2 2015 Cooper Companies Inc Earnings Release - 4:00PM EDT - Add to calendar
Mar 16, 2015
Cooper Companies Inc Annual Shareholders Meeting
Mar 5, 2015
Q1 2015 Cooper Companies Inc Earnings Call
Mar 5, 2015
Q1 2015 Cooper Companies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '15) 2014
Net profit margin 13.87% 15.82%
Operating margin 16.42% 17.84%
EBITD margin - 25.89%
Return on average assets 5.63% 7.16%
Return on average equity 9.68% 10.85%
Employees 9,460 -
CDP Score - -


6140 Stoneridge Mall Rd Ste 590
PLEASANTON, CA 94588-3772
United States - Map
+1-925-4603600 (Phone)
+1-925-4603649 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


The Cooper Companies, Inc. (Cooper), is a global medical device company. The Company operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Fertility Clinic. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism, presbyopia and ocular dryness, and provides innovative contact lens solutions. The CooperVision Company’s brands include Biofinity, Avaira and MyDay and CooperSurgical Company’s brands include Advincula Arch, SeeClear and Mobius.

Officers and directors

A. Thomas Bender Independent Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Weiss Chief Executive Officer, Director
Age: 68
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Allan E. Rubenstein M.D. Vice Chairman of the Board, Lead Director, Independent Director
Bio & Compensation  - Reuters
Gregory W. Matz Chief Financial Officer, Senior Vice President, Chief Risk Officer
Age: 55
Bio & Compensation  - Reuters
Paul L. Remmell President and Chief Executive Officer of CooperSurgical Inc.
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel G. McBride Esq. Chief Operating Officer, Executive Vice President; President of CooperVision, Inc.
Age: 50
Bio & Compensation  - Reuters
Carol R. Kaufman Executive Vice President, Chief Administrative Officer, Secretary, Chief Governance Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Albert G. White III Senior Vice President, Chief Strategy Officer
Age: 45
Bio & Compensation  - Reuters
Randal L. Golden Esq. Vice President, Controller
Age: 53
Bio & Compensation  - Reuters
Tina Maloney Vice President, Controller
Age: 52
Bio & Compensation  - Reuters